Form 8-K - Current report:
SEC Accession No. 0000950170-24-118950
Filing Date
2024-10-30
Accepted
2024-10-30 16:01:21
Documents
68
Period of Report
2024-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dawn-20241030.htm   iXBRL 8-K 49760
2 EX-99.1 dawn-ex99_1.htm EX-99.1 132644
3 EX-99.2 dawn-ex99_2.htm EX-99.2 15553
4 EX-99.3 dawn-ex99_3.htm EX-99.3 48909
5 GRAPHIC img109617361_0.jpg GRAPHIC 9664
6 GRAPHIC dawn-ex99_2s1.jpg GRAPHIC 146004
7 GRAPHIC dawn-ex99_2s2.jpg GRAPHIC 678473
8 GRAPHIC dawn-ex99_2s3.jpg GRAPHIC 213830
9 GRAPHIC dawn-ex99_2s4.jpg GRAPHIC 122292
10 GRAPHIC dawn-ex99_2s5.jpg GRAPHIC 291798
11 GRAPHIC dawn-ex99_2s6.jpg GRAPHIC 132758
12 GRAPHIC dawn-ex99_2s7.jpg GRAPHIC 224796
13 GRAPHIC dawn-ex99_2s8.jpg GRAPHIC 227383
14 GRAPHIC dawn-ex99_2s9.jpg GRAPHIC 260218
15 GRAPHIC dawn-ex99_2s10.jpg GRAPHIC 337124
16 GRAPHIC dawn-ex99_2s11.jpg GRAPHIC 304130
17 GRAPHIC dawn-ex99_2s12.jpg GRAPHIC 221020
18 GRAPHIC dawn-ex99_2s13.jpg GRAPHIC 132623
19 GRAPHIC dawn-ex99_2s14.jpg GRAPHIC 350524
20 GRAPHIC dawn-ex99_2s15.jpg GRAPHIC 119624
21 GRAPHIC dawn-ex99_3s1.jpg GRAPHIC 199823
22 GRAPHIC dawn-ex99_3s2.jpg GRAPHIC 669685
23 GRAPHIC dawn-ex99_3s3.jpg GRAPHIC 380389
24 GRAPHIC dawn-ex99_3s4.jpg GRAPHIC 320761
25 GRAPHIC dawn-ex99_3s5.jpg GRAPHIC 223044
26 GRAPHIC dawn-ex99_3s6.jpg GRAPHIC 356372
27 GRAPHIC dawn-ex99_3s7.jpg GRAPHIC 422145
28 GRAPHIC dawn-ex99_3s8.jpg GRAPHIC 322183
29 GRAPHIC dawn-ex99_3s9.jpg GRAPHIC 336267
30 GRAPHIC dawn-ex99_3s10.jpg GRAPHIC 320756
31 GRAPHIC dawn-ex99_3s11.jpg GRAPHIC 378233
32 GRAPHIC dawn-ex99_3s12.jpg GRAPHIC 327270
33 GRAPHIC dawn-ex99_3s13.jpg GRAPHIC 307146
34 GRAPHIC dawn-ex99_3s14.jpg GRAPHIC 265892
35 GRAPHIC dawn-ex99_3s15.jpg GRAPHIC 214328
36 GRAPHIC dawn-ex99_3s16.jpg GRAPHIC 185725
37 GRAPHIC dawn-ex99_3s17.jpg GRAPHIC 370896
38 GRAPHIC dawn-ex99_3s18.jpg GRAPHIC 240469
39 GRAPHIC dawn-ex99_3s19.jpg GRAPHIC 251411
40 GRAPHIC dawn-ex99_3s20.jpg GRAPHIC 300237
41 GRAPHIC dawn-ex99_3s21.jpg GRAPHIC 319521
42 GRAPHIC dawn-ex99_3s22.jpg GRAPHIC 353859
43 GRAPHIC dawn-ex99_3s23.jpg GRAPHIC 355667
44 GRAPHIC dawn-ex99_3s24.jpg GRAPHIC 371439
45 GRAPHIC dawn-ex99_3s25.jpg GRAPHIC 98743
46 GRAPHIC dawn-ex99_3s26.jpg GRAPHIC 350580
47 GRAPHIC dawn-ex99_3s27.jpg GRAPHIC 321019
48 GRAPHIC dawn-ex99_3s28.jpg GRAPHIC 300455
49 GRAPHIC dawn-ex99_3s29.jpg GRAPHIC 337562
50 GRAPHIC dawn-ex99_3s30.jpg GRAPHIC 402320
51 GRAPHIC dawn-ex99_3s31.jpg GRAPHIC 232666
52 GRAPHIC dawn-ex99_3s32.jpg GRAPHIC 304038
53 GRAPHIC dawn-ex99_3s33.jpg GRAPHIC 444672
54 GRAPHIC dawn-ex99_3s34.jpg GRAPHIC 397448
55 GRAPHIC dawn-ex99_3s35.jpg GRAPHIC 389139
56 GRAPHIC dawn-ex99_3s36.jpg GRAPHIC 399620
57 GRAPHIC dawn-ex99_3s37.jpg GRAPHIC 383008
58 GRAPHIC dawn-ex99_3s38.jpg GRAPHIC 371724
  Complete submission text file 0000950170-24-118950.txt   22839004

Data Files

Seq Description Document Type Size
59 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dawn-20241030.xsd EX-101.SCH 23893
70 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20241030_htm.xml XML 4552
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 241410190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)